v3.26.1
Note 19 - Segment Information - Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash and cash equivalents $ 12,645 $ 2,002
Prepaid expenses and other current assets 346 240
Property and equipment, net 12,641 2
Deferred offering costs 136 49
Licensed technology, net 2,243 0
Goodwill 3,457 0
Other assets 124 0
Total consolidated assets of continuing operations 31,607 2,807
Research and development 3,131 1,313
Selling, general and administrative 4,767 3,163
Total operating expenses 7,898 4,476
Change in fair value of derivative liability 28 0
Interest income 23 6
Interest expense (146) 0
Net other (expense) income (95) 6
Net loss from operations before discontinued operations (7,993) $ (4,470)
Biopharma [Member]    
Research and development 2,776  
Selling, general and administrative 4,575  
Total operating expenses 7,351  
Change in fair value of derivative liability 28  
Interest income 23  
Interest expense (146)  
Net other (expense) income (95)  
Net loss from operations before discontinued operations (7,446)  
CDMO [Member]    
Research and development 355  
Selling, general and administrative 192  
Total operating expenses 547  
Change in fair value of derivative liability 0  
Interest income 0  
Interest expense 0  
Net other (expense) income 0  
Net loss from operations before discontinued operations (547)  
Continuing Operations [Member]    
Cash and cash equivalents 12,645  
Prepaid expenses and other current assets 346  
Property and equipment, net 12,641  
Deferred offering costs 136  
Licensed technology, net 2,243  
Goodwill 3,457  
Other assets 124  
Total consolidated assets of continuing operations 31,592  
Continuing Operations [Member] | Biopharma [Member]    
Cash and cash equivalents 12,277  
Prepaid expenses and other current assets 156  
Property and equipment, net 34  
Deferred offering costs 136  
Licensed technology, net 2,243  
Goodwill 0  
Other assets 124  
Total consolidated assets of continuing operations 14,970  
Continuing Operations [Member] | CDMO [Member]    
Cash and cash equivalents 368  
Prepaid expenses and other current assets 190  
Property and equipment, net 12,607  
Deferred offering costs 0  
Licensed technology, net 0  
Goodwill 3,457  
Other assets 0  
Total consolidated assets of continuing operations $ 16,622